Emergent BioSolutions (EBS) Common Equity (2010 - 2026)
Emergent BioSolutions (EBS) posted Common Equity of $341.4 million for Q2 2026, down 34.74% on a QoQ basis from $523.1 million in Q1 2026, and down 36.33% year-over-year from $536.2 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Common Equity (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Common Equity for 17 years, with the latest figure at $341.4 million in Q2 2026.
- On a quarterly basis, Common Equity fell 36.33% year-over-year to $341.4 million in Q2 2026; TTM through Jun 2026 was $341.4 million, a 36.33% decrease from a year earlier, with the FY2025 full-year figure at $522.6 million, up 8.24% from the prior year.
- Common Equity was $341.4 million for Q2 2026 at Emergent BioSolutions, down from $523.1 million in the prior quarter.
- The five-year high for Common Equity was $1.6 billion in Q1 2022, with the low at $341.4 million in Q2 2026.
- Average Common Equity over 5 years is $805.8 million, with a median of $615.9 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Common Equity plunged 59.66% in 2024, then soared 38.8% in 2025.
- Over 5 years, Common Equity stood at $1.4 billion in 2022, then slumped by 53.21% to $649.3 million in 2023, then dropped by 25.64% to $482.8 million in 2024, then gained by 8.24% to $522.6 million in 2025, then tumbled by 34.67% to $341.4 million in 2026.
- The last three Common Equity figures came in at $341.4 million (Q2 2026), $523.1 million (Q1 2026), and $522.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 106.07 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 85.49 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 22.32 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 80.86 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 5.17 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 2.61 Bn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 341.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 341.40 Mn |
| Mar 31, 2026 | 523.10 Mn |
| Dec 31, 2025 | 522.60 Mn |
| Sep 30, 2025 | 582.50 Mn |
| Jun 30, 2025 | 536.20 Mn |
| Mar 31, 2025 | 552.70 Mn |
| Dec 31, 2024 | 482.80 Mn |
| Sep 30, 2024 | 508.40 Mn |
| Jun 30, 2024 | 386.30 Mn |
| Mar 31, 2024 | 663.90 Mn |
| Dec 31, 2023 | 649.30 Mn |
| Sep 30, 2023 | 697.20 Mn |
| Jun 30, 2023 | 957.70 Mn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.61 Bn |
| Sep 30, 2021 | 1.52 Bn |
API Access
Emergent BioSolutions Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();